LH
Laboratory Corp. of America Holdings
$216.99
Earnings Summary
Revenue | $2428.4Mn |
Net Profits | $184.4Mn |
Net Profit Margins | 7.59% |
Highlights
Laboratory Corp. of America Holdings’s revenue jumped 5.56% since last year same period to $2428.4Mn in the Q4 2016. On a quarterly growth basis, Laboratory Corp. of America Holdings has generated 0.57% jump in its revenue since last 3-months.
Laboratory Corp. of America Holdings’s net profit jumped 61.33% since last year same period to $184.4Mn in the Q4 2016. On a quarterly growth basis, Laboratory Corp. of America Holdings has generated 2.73% jump in its net profits since last 3-months.
Laboratory Corp. of America Holdings’s net profit margin jumped 52.83% since last year same period to 7.59% in the Q4 2016. On a quarterly growth basis, Laboratory Corp. of America Holdings has generated 2.15% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Laboratory Corp. of America Holdings post its latest quarter earnings
EPS Estimate Current Quarter | 4.13 |
EPS Estimate Current Year | 4.13 |
Highlights
Laboratory Corp. of America Holdings’s earning per share (EPS) estimates for the current quarter stand at 4.13 - a -11.56% fall from last quarter’s estimates.
Laboratory Corp. of America Holdings’s earning per share (EPS) estimates for the current year stand at 4.13.
Key Ratios
Key ratios of the Laboratory Corp. of America Holdings post its Q4 2022 earnings
Return on Assets (ROA) | 0.07 |
Return on Equity (ROE) | 0.13 |
Dividend Per Share (DPS) | 0.72 |
Highlights
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Laboratory Corp. of America Holdings’s return on assets (ROA) stands at 0.07.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Laboratory Corp. of America Holdings’s return on equity (ROE) stands at 0.13.
Laboratory Corp. of America Holdings declared 0.72 dividend per share during the earnings announcement for Q4 2022.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2016-07-29 | 2.3 | 2.31 | 0.43% |
2017-02-27 | 2.13 | 2.15 | 0.94% |
2016-10-28 | 2.29 | 2.25 | -1.75% |
2016-05-06 | 1.96 | 2.02 | 3.06% |
Company Information
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, company provides insights and accelerates innovations to improve health and improve lives. With more than 70,000 employees, Labcorp serves clients in more than 100 countries. Labcorp reported revenue of $14 billion in FY2020.
Organisation | Laboratory Corp. of America Holdings |
Headquarters | 358 South Main Street, Burlington, NC, United States, 27215 |
Employees | 70400 |
Industry | Health Services |
CEO | Adam Schechter |
